Chicos FAS (CHS) Misses Q2 EPS by 15c

Chicos FAS (NYSE: CHS) reported Q2 EPS of ($0.40), $0.15 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $306.2 million versus the consensus estimate of $346.17 million.

Fiscal 2020 Third Quarter and Full-Year Outlook

Given the ongoing market disruption caused by the pandemic and related uncertainty on timing and extent of the market recovery, the Company is not providing fiscal 2020 third-quarter or full-year guidance at this time.

For earnings history and earnings-related data on Chicos FAS (CHS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13